Claire E. Rojohn Iii

Array ( [id] => 6561873 [patent_doc_number] => 20100272734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH' [patent_app_type] => utility [patent_app_number] => 12/767509 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33600 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272734.pdf [firstpage_image] =>[orig_patent_app_number] => 12767509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807163 [patent_doc_number] => 20120058116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'FGFR1C ANTIBODY COMBINATIONS' [patent_app_type] => utility [patent_app_number] => 13/265887 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12357 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058116.pdf [firstpage_image] =>[orig_patent_app_number] => 13265887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266473 [patent_doc_number] => 20100298232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/799024 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 24946 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298232.pdf [firstpage_image] =>[orig_patent_app_number] => 12799024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220800 [patent_doc_number] => 20120135005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'ANTI-TNF-a ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 13/264983 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 26040 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234909 [patent_doc_number] => 20100266613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'ANTI-TNF-ALPHA ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/761745 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 24254 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266613.pdf [firstpage_image] =>[orig_patent_app_number] => 12761745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320557 [patent_doc_number] => 20100196383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'Connective Tissue Growth Factor (CTGF-3)' [patent_app_type] => utility [patent_app_number] => 12/761083 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20889 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196383.pdf [firstpage_image] =>[orig_patent_app_number] => 12761083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8141653 [patent_doc_number] => 20120094935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'METHODS FOR CREATING OR IDENTIFYING COMPOUNDS THAT BIND TUMOR NECROSIS FACTOR ALPHA' [patent_app_type] => utility [patent_app_number] => 13/263308 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 385627 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094935.pdf [firstpage_image] =>[orig_patent_app_number] => 13263308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675666 [patent_doc_number] => 08383780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Antibodies to TGFβ' [patent_app_type] => utility [patent_app_number] => 12/724347 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21326 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12724347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8126725 [patent_doc_number] => 20120087910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'SPARC ANGIOGENIC DOMAIN AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/256135 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15533 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20120087910.pdf [firstpage_image] =>[orig_patent_app_number] => 13256135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635998 [patent_doc_number] => 20100226928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Lyophilised Antibody Formulation' [patent_app_type] => utility [patent_app_number] => 12/718387 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8240 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226928.pdf [firstpage_image] =>[orig_patent_app_number] => 12718387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289933 [patent_doc_number] => 20100158918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Polypeptides and polynucleotides encoding same' [patent_app_type] => utility [patent_app_number] => 12/714930 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 36004 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158918.pdf [firstpage_image] =>[orig_patent_app_number] => 12714930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9850400 [patent_doc_number] => 08952130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => 'Designer ligands of TGF-β superfamily' [patent_app_type] => utility [patent_app_number] => 12/712069 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 43885 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12712069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580851 [patent_doc_number] => 20110294734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING TGF-BETA 1 INHIBITOR PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/147145 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15528 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294734.pdf [firstpage_image] =>[orig_patent_app_number] => 13147145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795905 [patent_doc_number] => 08124611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Inhibitors of the mutant form of kit' [patent_app_type] => utility [patent_app_number] => 12/700106 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1834 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124611.pdf [firstpage_image] =>[orig_patent_app_number] => 12700106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670018 [patent_doc_number] => 20110319287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'MODULATOR ASSAY' [patent_app_type] => utility [patent_app_number] => 13/145248 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 10669 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320444 [patent_doc_number] => 20100113363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Use of GLP-1 Peptides' [patent_app_type] => utility [patent_app_number] => 12/651685 [patent_app_country] => US [patent_app_date] => 2010-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5364 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113363.pdf [firstpage_image] =>[orig_patent_app_number] => 12651685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710242 [patent_doc_number] => 20120003234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Osteoarthritis treatment' [patent_app_type] => utility [patent_app_number] => 13/140467 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8811 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614524 [patent_doc_number] => 20100099620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Protracted GLP-1 Compositions' [patent_app_type] => utility [patent_app_number] => 12/642067 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2409 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099620.pdf [firstpage_image] =>[orig_patent_app_number] => 12642067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296729 [patent_doc_number] => 20100160608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'PROTEIN STABILIZER' [patent_app_type] => utility [patent_app_number] => 12/638063 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4666 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160608.pdf [firstpage_image] =>[orig_patent_app_number] => 12638063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487486 [patent_doc_number] => 20110236398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Antibody Formulation' [patent_app_type] => utility [patent_app_number] => 13/133843 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7346 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236398.pdf [firstpage_image] =>[orig_patent_app_number] => 13133843 [rel_patent_id] =>[rel_patent_doc_number] =>)